Markus Gershater looks at how automation and artificial intelligence (AI) can transform pharma R&D. Due to increasing complexity in R&D, pharma teams are under pressure to drive down costs and ...

set up a pharmaceutical business in 1876. He was a pioneer of new methods in the industry, being one of the first to focus on R&D as well as manufacturing. Another military man in the drugs ...

Pharmaceutical and hospital sector executives are requesting higher public healthcare spending, R&D incentives, and tax ...

French immunotherapy company OSE Immunotherapeutics has appointed Dr Sonya Montgomery as chief development officer. She will ...

Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare ...

10 January 2025 The US Food and Drug Administration approved 50 novel drugs in 2024, continuing to outpace its global regulatory peers.

To identify this year’s Drugs to Watch 2025 list, Clarivate drew from expertise from over 160 Clarivate analysts covering ...

We can’t make true progress on unmet medical needs unless we understand what the patients themselves think they need or say is missing from their treatment options.

The Arch-backed startup begins life with several assets acquired from Denali Therapeutics. Elsewhere, Jasper got a negative ...

French biotech MaaT Phar­ma says its acute graft-ver­sus-host dis­ease treat­ment ex­ceed­ed ex­pec­ta­tions in a sin­gle-arm Phase 3 study in Eu­rope.

Tiwari, who serves as Senior Vice President at the world’s top asset management firm, emphasized the transformative potential ...